Fibrocell Science Inc (FCSC):企業のM&A・提携動向(医療機器分野)

◆英語タイトル:Fibrocell Science Inc (FCSC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME214199D
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年1月24日
◆ページ数:28
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥55,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥83,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Fibrocell Science Inc (Fibrocell Science) is an autologous cell therapy company which develops products for treating skin diseases and conditions with high unmet medical needs. The company’s commercial product portfolio includes LAVIV (azficel-T), an aesthetic cell therapy for improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults; and Autologous Creme, an autologous skin care cream that contains growth factors and proteins derived from a person’s own fibroblasts. Fibrocell Science’s product pipeline comprises medical development programs for the treatment of restrictive burn scars, vocal cord scars and recessive dystrophic epidermolysis bullosa; and aesthetic development programs to treat acne scars. It operates along with its subsidiaries in the US, the UK, Australia and Switzerland. Fibrocell Science is headquartered in Exton, Pennsylvania, the US.

Fibrocell Science Inc (FCSC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Fibrocell Science Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fibrocell Science Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Fibrocell Science Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fibrocell Science Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Fibrocell Science Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Fibrocell Science Inc, Medical Equipment, Deal Details 10
Partnerships 10
Fibrocell Science Enters Into Research Agreement With University Of California 10
Fibrocell Science Enters into Licensing Agreement with University of California to Advance the Development of Personalized Cell Therapies 10
Fibrocell Science Enters Into Licensing Agreement With University of California 11
Equity Offering 12
Fibrocell Science Completes Final Tranche Of Private Placement For US$3.4 Million 12
Debt Offering 13
Fibrocell Science Raises USD18.1 Million in Private Placement of Notes and Warrants 14
Fibrocell Science Inc – Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 03, 2016: Fibrocell Reports Third Quarter 2016 Financial Results and Recent Operational Highlights 18
Aug 04, 2016: Fibrocell Reports Second Quarter 2016 Financial Results and Recent Operational Highlights 20
May 05, 2016: Fibrocell Reports First Quarter 2016 Financial Results and Operational Highlights 22
Mar 10, 2016: Fibrocell Reports Fourth Quarter and Full Year 2015 Financial Results and Operational Highlights 24
Corporate Communications 26
Dec 19, 2016: Fibrocell Announces Leadership Changes 26
Nov 10, 2016: Fibrocell Appoints Alfred T. Lane, MD, Chief Medical Advisor 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Fibrocell Science Inc, Medical Equipment, Key Facts, 2015 1
Fibrocell Science Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Fibrocell Science Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fibrocell Science Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Fibrocell Science Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fibrocell Science Inc, Deals By Market, 2011 to YTD 2017 8
Fibrocell Science Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Fibrocell Science Enters Into Research Agreement With University Of California 10
Fibrocell Science Enters into Licensing Agreement with University of California to Advance the Development of Personalized Cell Therapies 10
Fibrocell Science Enters Into Licensing Agreement With University of California 11
Fibrocell Science Completes Final Tranche Of Private Placement For US$3.4 Million 12
Fibrocell Science Raises USD18.1 Million in Private Placement of Notes and Warrants 14
Fibrocell Science Inc, Key Competitors 15
Fibrocell Science Inc, Key Employees 16
Fibrocell Science Inc, Subsidiaries 17

List of Figures
Fibrocell Science Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Fibrocell Science Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Fibrocell Science Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Fibrocell Science Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Fibrocell Science Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fibrocell Science Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Fibrocell Science Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fibrocell Science Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Fibrocell Science Inc (FCSC):企業のM&A・提携動向(医療機器分野)(Fibrocell Science Inc (FCSC) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆